Sandu Pharmaceuticals Ltd Q1FY24 consolidated net profit declines to Rs. 10.93 lakhs

SANDU PHARMACEUTICALS LTD. has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 17.6581 crores during the period ended June 30, 2023 as compared to Rs. 15.3097 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 0.1093 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 0.2717 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 0.11 for the period ended June 30, 2023 as compared to Rs. 0.26 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 17.6581 crs	₹15.3097 crs	15.34%
Net Profit	₹0.1093 crs	₹0.2717 crs	-59.77%
EPS	₹0.11	₹0.26	-57.69%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 17.6581 crores during the period ended June 30, 2023 as compared to Rs.16.3144 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.0.1093 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.0.1693 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.0.11 for the period ended June 30, 2023 as compared to Rs.0.18 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 17.6581 crs	₹16.3144 crs	8.24%
Net Profit	₹0.1093 crs	₹0.1693 crs	-35.44%
EPS	₹0.11	₹0.18	-38.89%

Shares of SANDU PHARMACEUTICALS LTD. was last trading in BSE at Rs. 55.51 as compared to the previous close of Rs. 55.44. The total number of shares traded during the day was 1044 in over 24 trades.

The stock hit an intraday high of Rs. 59.38 and intraday low of 55.01. The net turnover during the day was Rs. 58117.00.

Source : Equity Bulls

Keywords

SanduPharmaceuticals Q1FY24 ResultUpdate